Comparison of four aortic bioprostheses: Hancock II vs. St Jude Trifecta vs. Carpentier-Edwards Perimount Magna vs. Magna Ease-mid-term results (COMPARE SAVR study).

J Thorac Dis · 2024 · PMC11388261 · PMID 39268099

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Better survival rates were noted in the Trifecta group, but the results did not reach statistical significance.

also in 111,027 other papers

highly significantno p-value reported

The incidence of severe PPM in this study was 0.6% in the Trifecta cohort and 8.5% in the Magna Ease cohort, which was highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Comparison of four aortic bioprostheses: Hancock II <i>vs.</i> St Jude Trifecta <i>vs.</i> Carpentier-Edwards Perimount Magna <i>vs.</i> Magna Ease-mid-term results (COMPARE SAVR study).

The sentences